Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders
Further to the announcement of the recommended acquisition of Shire plc (“Shire”) on May 8, 2018 (“the Acquisition”), Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda” or the “Company”) today announced that the Company has established the record date for the Extraordinary General Meeting of Shareholders, to vote on the necessary matters relating to the proposed Acquisition as follows.
Record Date Regarding the Extraordinary General Meeting of Shareholders
Takeda has set October 19, 2018 as the record date. Shareholders recorded in the final shareholder registry on that date shall be entitled to exercise voting rights at the Extraordinary General Meeting of Shareholders. Establishment of an October 19, 2018 record date gives the company the discretion to hold the Extraordinary General Meeting of Shareholders within the three month period ending January 18, 2019. If the company does not decide to hold the Extraordinary General Meeting of Shareholders on any date falling within the three month period ending January 18, 2019, a new record date will be established and announced.
|1.||Record date:||October 19, 2018|
|2.||Date of public notice:||October 1, 2018|
|3.||Method of public notice:||
The relevant information will be posted on the Takeda website by an
Significant Progress To-Date
Since the announcement of the recommended offer on May 8, 2018, Takeda has successfully completed several significant milestones in the Acquisition process, including:
- Entering into a USD 7.5 billion term loan credit agreement with leading global financial institutions.
- Confirming a post-closing focus on key therapeutic areas including gastroenterology, oncology, neuroscience and rare diseases as well as vaccines and plasma-derived therapies.
- Developing a future operating model as part of planning efforts to facilitate the successful integration of Takeda and Shire following completion of the Acquisition. Takeda is planning to implement a lean post-closing organizational structure with clearly-defined accountabilities and ownership. The future operating model is intended to further strengthen Takeda’s patient- and customer-centric organization.
- Receipt of unconditional clearance from regulatory agencies in a number of key jurisdictions, including the United States Federal Trade Commission, the Brazilian Administrative Council for Economic Defense and the State Administration for Market Regulation in China, among other regulatory authorities.
The Acquisition will create a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. It will strengthen Takeda’s presence in the United States, an important and growing market, will reinforce our pipeline, and provide cash flow to continue to invest in our R&D engine while creating a more competitive, agile and highly profitable company.
The significantly strengthened cash flow generation which the Acquisition is expected to provide will support the maintenance of Takeda’s well-established dividend policy and facilitate rapid de-leveraging to a net debt to EBITDA ratio of 2.0x or less within three to five years following closing of the Acquisition. To help accelerate the de-leveraging process and ensure an optimal business mix, Takeda may consider selected divestitures of non-core businesses.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda. Approximately 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries.
For more information, visit https://www.takeda.com/newsroom/.
Takeda (Investor Relations)
Takashi Okubo, +81 3 3278 2306
Takeda (Media - outside Japan)
Elissa Johnsen, +1 312 285 3203
Takeda (Media - within Japan)
Kazumi Kobayashi, +81 3 3278 2095
Tsuyoshi Tada, +81 3 3278 2417
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
ZT Acquires Both Mobile & IoT Messaging and Interact Business Units From NewNet18.12.2018 10:17 | Pressemelding
ZephyrTel, a division of ESW Capital focused exclusively on global telecommunications operators, is pleased to announce it has acquired the Interact and Mobile Messaging business units of NewNet Communication Technologies with immediate effect. The acquisition will integrate the Mobile Messaging, Invigorate Rating and Charging Platform and the Nimblevox Cloud IVR technology into the ZephyrTel rapidly growing Telecoms Cloud Portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181218005330/en/ ZephyrTel's CEO, Mike Shinya (Photo: Business Wire) ZephyrTel has built a world-class telecommunication Cloud software company to provide software solutions and services to the global telco industry. The company’s primary objective is to provide carrier-grade Cloud applications and Cloud enablement products. The goal being to deliver industry-leading throughput, robustness, scale and value to its customers at the pace they need. Zep
AccelStor Renews License Agreement with Login VSI18.12.2018 10:00 | Pressemelding
AccelStor, the manufacturer of award-winning all-flash arrays (AFAs), announced the multi-year renewal of the license agreement with Login VSI (www.loginvsi.com), the industry standard in VDI and SBC performance testing. Login VSI will be used in AccelStor’s R&D labs and Technical Marketing materials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181218005030/en/ AccelStor Renews License Agreement with Login VSI (Photo: Business Wire) “We are committed to providing our VDI customers with the best possible end-user experience. This means we are 100% focused on the optimal performance and scalability of our solutions,” says Stefan Ferrari, Technical Sales Director of AccelStor. “The Login VSI software helps us build superior products and demonstrate the power of our solutions in an objective and industry standard way.” Login VSI will be used in the R&D laboratories of AccelStor in Taipei, Taiwan; Fremont, CA; and London, UK;
Ammeraal Beltech and Megadyne Group Announce Their New Merged Name18.12.2018 09:00 | Pressemelding
The two world-leading suppliers in belting technology – Ammeraal Beltech and Megadyne Group – who came together in a merger in September of this year, have taken another important step in their integration. This month, they have announced a new corporate name for their joint operations: AMMEGA. The integration of these two companies to effectively create a new belting champion spanning industrial power transmission belting and lightweight conveyor belting is ongoing, and continues apace. The new name of AMMEGA will serve principally to unite all of its employees under a common identity and corporate vision and mission. In view of their well-established reputations in their respective markets and their different channel-to-market strategies, which will remain unchanged, their two strong brand names – Ammeraal Beltech and Megadyne – will remain as is. “Ensuring continuity, especially in the way we serve our valued customers, is a top priority,” explains Marc Maisonneuve, AMMEGA’s Corpora
Belfius Selects Moody’s Analytics IFRS 17 Solution18.12.2018 08:30 | Pressemelding
Moody’s Analytics, a leading provider of financial intelligence, announced today that its technology has been selected by Belfius, a major bank insurer in Belgium. Belfius is using the Moody’s Analytics RiskIntegrity™ IFRS 17 solution to make the transition from their current insurance accounting frameworks to the new International Financial Reporting Standard (IFRS 17) that becomes effective for the 2022 reporting year. The Moody’s Analytics RiskIntegrity IFRS 17 solution helps insurance entities of any size to meet the new reporting challenges. It integrates seamlessly with existing infrastructure, connecting data, models, systems, and processes between actuarial and accounting functions. “Our decision to work with Moody’s Analytics followed an extensive trial of the Moody’s Analytics RiskIntegrity IFRS 17 solution to prove it was the appropriate solution to integrate with our current actuarial and accounting systems,” said Lies Gevaert, Chief Accountant at Belfius. “We are confident
Seoul Semiconductor Obtained Permanent Injunction against Everlight’s LED Products and Recall of Such Products from German Court18.12.2018 08:00 | Pressemelding
Seoul Semiconductor Co., Ltd. (KOSDAQ:046890) (“Seoul”), a leading global innovator of LED products and technology, announced that Seoul won a patent infringement lawsuit against a global distributor of Everlight LED products in Germany. The German court issued a permanent injunction against the sales of the accused Everlight products and ordered the distributor to recall such products from commercial customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181218005261/en/ The Patented Technology Improving Light Intensity and Brightness (Graphic: Business Wire) In March 2017, Seoul filed a patent infringement lawsuit in Germany at the District Court of Düsseldorf against Mouser Electronic Inc, accusing the distribution of certain Everlight LED products to infringe a patent that Seoul was enforcing. After 20 months of litigation proceedings, the Court rendered judgments in favor of SSC’s infringement claims, including order
RagingWire Develops New Santa Clara SV1 Data Center in the Heart of Silicon Valley18.12.2018 00:00 | Pressemelding
RagingWire Data Centers, Inc., the premier data center provider in North America and part of the global data center platform of NTT Communications (NTT Com), the information and communications technology (ICT) solutions and international communications business within the NTT Group (TOKYO:9432), today announced that it has purchased land and has begun developing a new world-class, 16 megawatt data center “California Silicon Valley 1 (SV1) Data Center” in Santa Clara, the heart of the tech capital of the world – Silicon Valley. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005270/en/ Planned for availability in July 2020, RagingWire’s SV1 marks the company’s entry into the Silicon Valley region, which is widely known as the No. 2 data center market in the United States behind Ashburn, Va., in terms of commissioned power. RagingWire also has significant data center campuses in Ashburn, Va., Dallas, Texas, and Sacramento